MSR
ABBV icon

Main Street Research’s AbbVie ABBV Stock Holding History

Main Street Research’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.45M Sell
9,721
-537
-5% -$116K 0.12% 49
2026
Q1 		$2.23M Buy
10,258
+903
+10% +$200K 0.13% 50
2025
Q4 		$2.14M Sell
9,355
-162
-2% -$36.9K 0.12% 45
2025
Q3 		$2.2M Buy
9,517
+415
+5% +$84.5K 0.12% 50
2025
Q2 		$1.69M Sell
9,102
-216
-2% -$40.1K 0.11% 48
2025
Q1 		$1.95M Sell
9,318
-157
-2% -$30.5K 0.13% 49
2024
Q4 		$1.68M Sell
9,475
-198
-2% -$36.4K 0.1% 49
2024
Q3 		$1.91M Sell
9,673
-49
-0.5% -$9.14K 0.12% 50
2024
Q2 		$1.67M Sell
9,722
-262
-3% -$43.4K 0.11% 49
2024
Q1 		$1.82M Sell
9,984
-170
-2% -$29.3K 0.12% 48
2023
Q4 		$1.57M Buy
10,154
+343
+3% +$50K 0.13% 48
2023
Q3 		$1.46M Buy
9,811
+6
+0.1% +$881 0.15% 51
2023
Q2 		$1.32M Sell
9,805
-1,924
-16% -$282K 0.21% 43
2023
Q1 		$1.87M Sell
11,729
-102
-0.9% -$15.6K 0.37% 31
2022
Q4 		$1.91M Sell
11,831
-291
-2% -$44.6K 0.47% 27
2022
Q3 		$1.63M Buy
12,122
+684
+6% +$98.2K 0.36% 26
2022
Q2 		$1.75M Buy
11,438
+76
+0.7% +$11.6K 0.46% 24
2022
Q1 		$1.84M Sell
11,362
-1,426
-11% -$207K 0.17% 43
2021
Q4 		$1.73M Buy
12,788
+2,100
+20% +$248K 0.13% 50
2021
Q3 		$1.15M Buy
10,688
+483
+5% +$55.2K 0.1% 59
2021
Q2 		$1.15M Buy
10,205
+293
+3% +$33K 0.09% 65
2021
Q1 		$1.07M Sell
9,912
-93
-0.9% -$9.95K 0.1% 62
2020
Q4 		$1.07M Sell
10,005
-288
-3% -$27.7K 0.12% 57
2020
Q3 		$902K Buy
10,293
+83
+0.8% +$7.81K 0.11% 56
2020
Q2 		$1M Buy
10,210
+2,418
+31% +$213K 0.16% 47
2020
Q1 		$594K Buy
7,792
+369
+5% +$31.4K 0.15% 47
2019
Q4 		$657K Sell
7,423
-720
-9% -$59.8K 0.1% 58
2019
Q3 		$617K Sell
8,143
-900
-10% -$61.7K 0.12% 53
2019
Q2 		$658K Buy
9,043
+500
+6% +$39.3K 0.15% 49
2019
Q1 		$688K Buy
8,543
+390
+5% +$31.9K 0.22% 41
2018
Q4 		$752K Sell
8,153
-153,877
-95% -$13.5M 0.29% 34
2018
Q3 		$15.3M Buy
162,030
+11,449
+8% +$1.09M 2.2% 23
2018
Q2 		$14M Sell
150,581
-1,485
-1% -$145K 2.18% 23
2018
Q1 		$14.4M Buy
152,066
+7,491
+5% +$823K 2.28% 18
2017
Q4 		$14M Buy
144,575
+2,444
+2% +$230K 2.13% 17
2017
Q3 		$12.6M Buy
142,131
+97,386
+218% +$7.41M 2.04% 20
2017
Q2 		$3.24M Buy
44,745
+19,005
+74% +$1.28M 0.53% 50
2017
Q1 		$1.68M Buy
25,740
+2,080
+9% +$131K 0.29% 58
2016
Q4 		$1.48M Buy
23,660
+1,172
+5% +$71.5K 0.29% 57
2016
Q3 		$1.42M Sell
22,488
-438
-2% -$28.4K 0.28% 61
2016
Q2 		$1.42M Sell
22,926
-409
-2% -$24.9K 0.29% 59
2016
Q1 		$1.33M Sell
23,335
-965
-4% -$53.8K 0.34% 53
2015
Q4 		$1.44M Sell
24,300
-110
-0.5% -$6.34K 0.31% 68
2015
Q3 		$1.45M Buy
24,410
+326
+1% +$21.2K 0.34% 66
2015
Q2 		$1.62M Buy
24,084
+479
+2% +$31.3K 0.33% 76
2015
Q1 		$1.38M Buy
23,605
+1,345
+6% +$81.3K 0.3% 76
2014
Q4 		$1.46M Sell
22,260
-95
-0.4% -$5.99K 0.31% 76
2014
Q3 		$1.29M Hold
22,355
– – 0.29% 83
2014
Q2 		$1.26M Sell
22,355
-434
-2% -$22.8K 0.3% 78
2014
Q1 		$1.17M Buy
22,789
+1,721
+8% +$87K 0.28% 77
2013
Q4 		$1.11M Sell
21,068
-350
-2% -$17.2K 0.28% 83
2013
Q3 		$958K Sell
21,418
-220
-1% -$9.75K 0.26% 85
2013
Q2 		$895K Buy
+21,638
New +$946K 0.27% 85

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Main Street Research's ABBV Position: Q2 2026 in Review

Main Street Research reduced its AbbVie (ABBV) stake by 5.2% in Q2 2026, selling an estimated $116K and leaving 9,721 shares worth $2.45M. The position accounts for 0.12% of the portfolio, ranked #49.

Main Street Research first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $15.3M in Q3 2018. 1,993 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Main Street Research held 9,721 shares of AbbVie worth $2.45M as of Q2 2026.
  • Main Street Research sold 537 AbbVie shares in Q2 2026, an estimated $116K.
  • AbbVie made up 0.12% of Main Street Research's portfolio in Q2 2026, its #49 holding.
  • Main Street Research first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • Main Street Research's AbbVie position peaked at $15.3M in Q3 2018.
  • 1,993 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Main Street Research's 13F filing for Q2 2026, filed 29 Jul 2026.